Distribution of AAV-TK following intracranial convection-enhanced delivery into rats

Cell Transplantation

Volumn 9, Issue 5, 2000, Pages 585-594

  Cunningham, Janet ^a   Oiwa, Yoshitsugu ^c   Nagy, Dea ^b   Podsakoff, Greg ^a   Colosi, Peter ^a   Bankiewicz, Krys S ^b,c  

^a Avigen Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adeno associated virus; Convection enhanced delivery; Intracranial delivery; Thymidine kinase (ACC TK)

Indexed keywords

THYMIDINE KINASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE EXPRESSION; GENE TARGETING; GLIOMA; INFUSION PUMP; KIDNEY; NERVE DEGENERATION; NONHUMAN; OSMOTIC PUMP; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SPINAL CORD; SPLEEN; TISSUE DISTRIBUTION;

ADENO-ASSOCIATED VIRUS; ANIMALIA;

EID: 0034533047     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900504     Document Type: Conference Paper

References (28)

1. Adeno-associated (AAV) viral vector-mediated gene delivery in non-human primates
2. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease
3. Selective and rapid uptake of adeno-associated virus type 2 in brain
4. Gene transfer to rodent brain with recombinant adenoviral vectors: Effects of infusion parameters, infectious titer, and virus concentration on transduction volume
5. Convection-enhanced delivery of macromolecules in the brain
6. Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination
7. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung
8. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption
9. Efficient transduction of human neurons with an adeno-associated virus vector
10. Stable in-vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector
11. Membrane depolarization induces calcium-dependant secretion of tissue plasminogen activator
12. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
13. Transfer and expression of potentially therapeutic genes into the mammalian central nervous system in-vivo using adeno-associated viral vectors
14. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
15. The impact of developmental stage, route of administration, and the immune system on adenovirus-mediated gene transfer
16. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors
17. Increasing volume of distribution to the brain with interstitial infusion: Dose, rather than convection, might be the most important factor
18. Effect of ischemic cerebral volume changes on behavior
19. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion
20. Basic fibroblast growth factor is highly neuroprotective against seizure-induced, long-term behavioural deficits
21. Adeno-associated virus vectors can be efficiently produced without helper virus
22. Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration
23. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: Distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons
24. Use of adeno-associated virus as a general transduction vector for mammalian cells
25. Gene therapy against an experimental glioma using adeno-associated virus vectors
26. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors
27. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo
28. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy